Larimar Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Larimar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Larimar Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Larimar Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $833k | 258k | 3.23 |
| 2025-06-30 | $313k | 108k | 2.89 |
| 2025-03-31 | $97k | 45k | 2.15 |
| 2024-12-31 | $206k | 53k | 3.87 |
| 2024-09-30 | $130k | 20k | 6.55 |
| 2024-06-30 | $128k | 18k | 7.25 |
| 2024-03-31 | $202k | 27k | 7.59 |
| 2023-12-31 | $128k | 28k | 4.55 |
| 2023-09-30 | $56k | 14k | 3.95 |
| 2023-06-30 | $90k | 29k | 3.13 |
| 2023-03-31 | $27k | 5.9k | 4.50 |
| 2022-12-31 | $297 | 72 | 4.13 |
| 2022-09-30 | $0 | 3.3k | 0.00 |
| 2022-06-30 | $0 | 601 | 0.00 |
| 2022-03-31 | $0 | 1.7k | 0.00 |
| 2021-12-31 | $0 | 1.1k | 0.00 |
| 2021-09-30 | $0 | 8 | 0.00 |
| 2021-06-30 | $0 | 8 | 0.00 |
| 2021-03-31 | $0 | 8 | 0.00 |
| 2020-12-31 | $6.0k | 299 | 20.07 |